Work

Low vs high dose carfilzomib (Cfz) with dexamethasone (Dex) for relapsed/refractory multiple myeloma (RRMM): Results of SWOG S1304.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.8015

Authors: Sikander Ailawadhi, Rachael Sexton, Suzanne Lentzsch, Muneer Hyder Abidi, Peter Michael Voorhees, Adam D. Cohen, Eric Rohren, Stephen Heitner, Kevin Kelly, Niklas J. Mackler, David M. Baer, Antje Hoering, Brian G. Durie, Robert Z. Orlowski

Institutions: Mayo Clinic in Florida, Cancer Research And Biostatistics, Columbia University Irving Medical Center, Spectrum Health, Carolinas Healthcare System, Levine Cancer Institute, Abramson Cancer Center, The University of Texas MD Anderson Cancer Center, Oregon Health & Science University, University of Southern California, USC Norris Comprehensive Cancer Center, Kaiser Permanente, Cedars-Sinai Medical Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2890046957

Cites:

Cited by: 1

Related to: 10